MONTPELIER HEALTH CENTRE — All Prescriptions & Medications — Page 2
Practice Code: L81012 | BRISTOL, BS6 5PT
Showing results 51-100 of 566
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Olanzapine | 798 | 17.0K | £3.3K | +115.4% ▲ |
| Gliclazide | 792 | 47.8K | £1.6K | -6.9% ▼ |
| Codeine phosphate | 786 | 55.3K | £1.9K | +9.4% ▲ |
| Macrogol 3350 | 772 | 50.5K | £8.4K | -17.7% ▼ |
| Cetirizine hydrochloride | 759 | 34.8K | £1.6K | +51.9% ▲ |
| Ferrous sulfate | 753 | 34.8K | £1.2K | +46.4% ▲ |
| Lamotrigine | 723 | 46.9K | £4.7K | +22.4% ▲ |
| Rivaroxaban | 714 | 18.8K | £12.2K | +16.7% ▲ |
| Aripiprazole | 703 | 13.5K | £2.6K | +176.3% ▲ |
| Amoxicillin | 700 | 35.1K | £955 | -24.9% ▼ |
| Fexofenadine hydrochloride | 676 | 28.7K | £1.2K | -20.5% ▼ |
| Senna | 674 | 20.1K | £537 | +12.0% ▲ |
| Ibuprofen | 673 | 70.1K | £1.9K | +32.3% ▲ |
| Fluoxetine hydrochloride | 661 | 30.6K | £1.9K | -34.8% ▼ |
| Levetiracetam | 646 | 60.0K | £4.3K | +41.1% ▲ |
| Insulin aspart | 642 | 4,131 | £25.2K | +68.6% ▲ |
| Risperidone | 637 | 13.4K | £663 | +151.8% ▲ |
| Other emollient preparations | 637 | 361.6K | £4.7K | +6.1% ▲ |
| Duloxetine hydrochloride | 626 | 17.0K | £1.7K | -1.5% vs avg |
| Docusate sodium | 599 | 33.6K | £2.5K | +61.6% ▲ |
| Sildenafil (Erectile Dysfunction) | 596 | 4,074 | £572 | +18.2% ▲ |
| Sumatriptan succinate | 593 | 5,780 | £9.2K | +67.5% ▲ |
| Allopurinol | 577 | 31.3K | £683 | -44.0% ▼ |
| Ezetimibe | 570 | 20.9K | £3.5K | -19.9% ▼ |
| Desogestrel | 568 | 51.7K | £1.4K | +43.3% ▲ |
| Combined ethinylestradiol 30mcg | 551 | 42.2K | £2.9K | +98.4% ▲ |
| Morphine sulfate | 544 | 88.9K | £3.4K | -17.0% ▼ |
| Promethazine hydrochloride | 539 | 17.3K | £2.1K | +50.8% ▲ |
| Gabapentin | 534 | 71.2K | £1.7K | -46.5% ▼ |
| 533 | 63.8K | £1.6K | +526.0% ▲ | |
| Budesonide | 529 | 873 | £22.1K | -2.4% ▼ |
| Latanoprost | 511 | 7,795 | £3.0K | +5.3% ▲ |
| Hydrocortisone | 507 | 15.0K | £4.8K | +13.1% ▲ |
| Solifenacin | 500 | 18.6K | £719 | +4.8% ▲ |
| Flucloxacillin sodium | 497 | 19.8K | £1.2K | +10.5% ▲ |
| 497 | 51.8K | £1.9K | +625.6% ▲ | |
| Rosuvastatin calcium | 490 | 20.8K | £977 | -45.4% ▼ |
| Finasteride | 478 | 11.7K | £441 | -27.0% ▼ |
| Sodium valproate | 475 | 59.9K | £5.3K | +49.3% ▲ |
| Estradiol with progestogen | 464 | 15.2K | £13.5K | +36.2% ▲ |
| Buprenorphine | 459 | 7,905 | £5.8K | +25.3% ▲ |
| Methotrexate | 447 | 7,670 | £9.7K | +37.3% ▲ |
| Betamethasone valerate | 445 | 37.5K | £2.2K | +15.6% ▲ |
| Lisdexamfetamine dimesylate | 441 | 13.6K | £32.6K | +269.3% ▲ |
| Carbocisteine | 439 | 39.9K | £1.2K | -17.8% ▼ |
| Alginic acid compound preparations | 438 | 221.3K | £2.3K | -25.2% ▼ |
| Bendroflumethiazide | 436 | 17.1K | £288 | -43.6% ▼ |
| Montelukast | 434 | 15.6K | £1.6K | -36.6% ▼ |
| Lithium carbonate | 428 | 11.7K | £2.4K | +237.4% ▲ |
| Other multivitamin preparations | 416 | 6,607 | £1.3K | +140.7% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.